Simris Group AB (PUBL) (STO:SIMRIS.B)
0.0444
+0.0012 (2.78%)
Jan 20, 2026, 5:09 PM CET
Simris Group AB (PUBL) Company Description
Simris Group AB (PUBL), a biotechnology company, develops, manufactures, and sells bioactive substances from microalgae in Sweden and internationally.
It offers skincare products and pharmaceuticals; food ingredients; and Algae Omega-3, an omega-3 EPA and DHA line under the SIMRIS brand name.
The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.
Simris Group AB (PUBL)
| Country | Sweden |
| Founded | 2011 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Daniel Kubitza |
Contact Details
Address: HerrestadsvAegen 24A Hammenhög, 276 50 Sweden | |
| Phone | 46 4 14 44 50 50 |
| Website | simrisgroup.com |
Stock Details
| Ticker Symbol | SIMRIS.B |
| Exchange | Nasdaq Stockholm |
| Share Class | Class B Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0008091664 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Kubitza | Interim Chief Executive Officer |
| Christoffer Tell | Chief Financial Officer |